Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Eshleman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1989 - 1992
Temple University HospitalInternship, Internal Medicine, 1988 - 1989
Perelman School of Medicine at the University of PennsylvaniaClass of 1988
Certifications & Licensure
MD State Medical License 1997 - 2026
PA State Medical License 1992 - 2006
OH State Medical License 1993 - 1998
American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetr...Andrei Gurau, Suguru Yamauchi, Kaitlyn Ecoff, Kristen P Rodgers, James R Eshleman
Non-Coding RNA Research. 2025-06-01 - Revision of interpretation criteria to define microsatellite instability in mismatch repair-deficient neoplasms with subtle electropherogram changes.Ming-Tseh Lin, Eric Christenson, Suping Chen, Emily Adams, Matthew Bayes
American Journal of Clinical Pathology. 2025-03-06 - Establishment and Characterization of Three Human Ocular Adnexal Sebaceous Carcinoma Cell Lines.Su-Chan Lee, Cornelia Peterson, Kaixuan Wang, Lujain Alaali, James Eshleman
International Journal of Molecular Sciences. 2024-09-23
Journal Articles
- Clinical Validation of Coexisting Driver Mutations in Colorectal CancersJunaid Ibrahim, James R Eshleman, Gang Zheng, Christopher D Gocke, Rena Xian, ScienceDirect
Press Mentions
FDA Clears Promega OncoMate™ MSI Dx Analysis SystemJuly 28th, 2021- PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyFebruary 10th, 2016
Grant Support
- Identifying Familial Pancreatic Cancer Predisposition GenesNational Cancer Institute2012
- Novel Human Cancer Cell Isolation SystemNational Cancer Institute2008–2011
- Novel Tumor Suppressor Gene Discovery In Pancreatic CancerNational Cancer Institute2007–2008
- Mutator Phenotypes In Microsatellite Stable Colon CancerNational Cancer Institute1999–2003
- Mechanisms Underlying Genetic Defects In Colon CancerNational Cancer Institute1997–2000
- Mechanisms Underlying Genetic Defects In Colon CancerNational Cancer Institute1996
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/james-eshleman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
